Delek US Holdings, Inc. (DK)
| Market Cap | 2.68B +189.5% |
| Revenue (ttm) | 10.73B -5.6% |
| Net Income | -51.40M |
| EPS | -0.87 |
| Shares Out | 61.29M |
| PE Ratio | n/a |
| Forward PE | 9.39 |
| Dividend | $1.02 (2.33%) |
| Ex-Dividend Date | May 1, 2026 |
| Volume | 168,157 |
| Open | 42.78 |
| Previous Close | 43.68 |
| Day's Range | 42.12 - 44.42 |
| 52-Week Range | 18.12 - 49.50 |
| Beta | 0.61 |
| Analysts | Buy |
| Price Target | 50.31 (+14.86%) |
| Earnings Date | Apr 29, 2026 |
About DK
Delek US Holdings, Inc. engages in the integrated downstream energy business in the United States. The company operates in two segments Refining and Logistics. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminals. It owns and operates refineries located in Tyler, Texas; El Dorado, Arkansas; Big Spring, Texas; and Krotz Springs, Louisiana. The Logis... [Read more]
Financial Performance
In 2025, Delek US Holdings's revenue was $10.72 billion, a decrease of -9.53% compared to the previous year's $11.85 billion. Losses were -$22.80 million, -95.93% less than in 2024.
Financial StatementsAnalyst Summary
According to 13 analysts, the average rating for DK stock is "Buy." The 12-month stock price target is $50.31, which is an increase of 14.86% from the latest price.
News
Delek US price target raised to $41 from $40 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Delek US (DK) to $41 from $40 and keeps an Equal Weight rating on the shares.
Delek US Holdings Earnings Call Transcript: Q1 2026
Q1 2026 saw strong operational execution, highlighted by the Big Spring turnaround and robust cash flow, despite a reported net loss. The company is well-positioned for the remainder of the year, with no major projects planned and strong demand outlook, especially in refining and logistics.
Delek US Holdings Earnings release: Q1 2026
Delek US Holdings released its Q1 2026 earnings on April 29, 2026, summarizing the period's financial results.
Delek US Holdings Slides: Q1 2026
Delek US Holdings has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 29, 2026.
Delek US Holdings Quarterly report: Q1 2026
Delek US Holdings has published its Q1 2026 quarterly earnings report on April 29, 2026.
Delek US Holdings Reports First Quarter 2026 Results
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Delek US Holdings, Inc. (NYSE: DK) (“Delek US”, "Company") today announced financial results for its first quarter ended March 31, 2026. “2026 is off to a strong sta...
Delek US price target lowered to $44 from $60 at TD Cowen
TD Cowen lowered the firm’s price target on Delek US (DK) to $44 from $60 and keeps a Hold rating on the shares. The firm adjusted targets in the refining…
Delek US price target raised to $40 from $38 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Delek US (DK) to $40 from $38 and keeps an Equal Weight rating on the shares. Refiners have given back most of…
Delek US Holdings Announces Refining Leadership Transition
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Delek US Holdings, Inc. (NYSE: DK) today announced the appointment of Amber Russell as Executive Vice President, Refining, effective April 20, 2026. In this role, Ms...
Delek US Holdings, Inc. Announces Quarterly Dividend
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Delek US Holdings, Inc. (NYSE:DK) (“Delek”) today announced that its Board of Directors has approved a quarterly dividend of $0.255 per share, to be paid on May 8, 2...
Delek US Holdings Transcript: AGM 2026
The meeting covered director elections, executive compensation, a new incentive plan, and auditor ratification. All management proposals passed, with no questions raised by stockholders during the session.
Delek US price target raised to $44 from $33 at Citi
Citi analyst Vikram Bagri raised the firm’s price target on Delek US (DK) to $44 from $33 and keeps a Neutral rating on the shares.
Delek US Holdings to Host First Quarter 2026 Conference Call on April 29th
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Delek US Holdings, Inc. (NYSE: DK) (“Delek US”) today announced that the Company intends to issue a press release summarizing first quarter 2026 results before the U...
Delek US price target raised to $48 from $42 at UBS
UBS analyst Manav Gupta raised the firm’s price target on Delek US (DK) to $48 from $42 and keeps a Neutral rating on the shares.
Delek US assumed with Buy from Neutral at Goldman Sachs
Goldman Sachs upgraded Delek US (DK) to Buy from Neutral with a $55 price target after assuming coverage of the name. The firm sees the company’s cost reduction efforts, small…
Delek US Holdings Proxy statement: Proxy filing
Delek US Holdings filed a proxy statement on March 27, 2026, providing details for shareholder voting and corporate governance matters.
Delek US price target raised to $54 from $47 at Raymond James
Raymond James raised the firm’s price target on Delek US (DK) to $54 from $47 and keeps an Outperform rating on the shares. Consensus estimates for Q1 may have risen…
Delek US price target raised to $40 from $28 at BofA
BofA raised the firm’s price target on Delek US (DK) to $40 from $28 and keeps an Underperform rating on the shares. The firm marks its 2026 price deck and…
Delek US price target raised to $54 from $51 at Mizuho
Mizuho raised the firm’s price target on Delek US (DK) to $54 from $51 and keeps an Outperform rating on the shares. The firm upped its 2026 oil price outlook…
Delek US Holdings Proxy statement: Proxy Filing
Delek US Holdings filed a proxy statement on March 10, 2026, providing details for shareholder voting and corporate governance matters.
Delek US Holdings Proxy statement: Proxy filing
Delek US Holdings filed a proxy statement on March 10, 2026, providing details for shareholder voting and corporate governance matters.
Delek US price target raised to $44 from $28 at TD Cowen
TD Cowen analyst Jason Gabelman raised the firm’s price target on Delek US (DK) to $44 from $28 and keeps a Hold rating on the shares. The firm updated its…
Delek US Holdings Earnings Call Transcript: Q4 2025
Q4 2025 saw strong financial results, with adjusted EBITDA of $375M and significant free cash flow improvements driven by the Enterprise Optimization Plan and early RIN monetization. DKL achieved record EBITDA, and guidance for 2026 remains robust, supported by operational enhancements and disciplined capital allocation.
Delek US Holdings Annual report: Q4 2025
Delek US Holdings has published its Q4 2025 annual report on February 27, 2026.
Delek US Holdings Earnings release: Q4 2025
Delek US Holdings released its Q4 2025 earnings on February 27, 2026, summarizing the period's financial results.